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Myosin is the primary regulator of muscle strength
and contractility. Here we show that three myosin
genes, Myh6, Myh7, and Myh7b, encode related
intronic microRNAs (miRNAs), which, in turn, control
muscle myosin content, myofiber identity, and
muscle performance. Within the adult heart, the
Myh6 gene, encoding a fast myosin, coexpresses
miR-208a, which regulates the expression of two
slow myosins and their intronic miRNAs, Myh7/miR-
208b and Myh7b/miR-499, respectively. miR-208b
andmiR-499 play redundant roles in the specification
ofmuscle fiber identity by activating slowand repres-
sing fast myofiber gene programs. The actions of
these miRNAs are mediated in part by a collection
of transcriptional repressors of slowmyofiber genes.
These findings reveal that myosin genes not only
encode the major contractile proteins of muscle,
but act more broadly to influence muscle function
by encoding a network of intronic miRNAs that
control muscle gene expression and performance.
INTRODUCTION
The speed and force of both myocardial and skeletal muscle
contraction are largely dependent on the intrinsic contractile
properties of cardiac and skeletal myocytes. Myosin heavy chain
(MHC) is the major contractile protein of cardiac and skeletal
muscle cells and the primary determinant of the efficiency of
muscle contraction. Cardiac and skeletal muscles modulate
the expression of myosin genes in response to hormonal
signaling and workload to meet physiological demands (Baldwin
and Haddad, 2001).
Cardiac contractility depends on the expression of two MHC
genes, a- and b-MHC (also known as Myh6 and Myh7, respec-
tively), which are linked in a head-to-tail orientation and are regu-
lated in an antithetical manner (Weiss and Leinwand, 1996). The
ratio of a- to b-MHC expression is species specific and varies in
response to developmental, physiological, and pathological
signaling. In rodents, b-MHC, a slowATPase, is highly expressed662 Developmental Cell 17, 662–673, November 17, 2009 ª2009 Ein the embryonic heart, whereas a-MHC, a fast ATPase, is
expressed at relatively low levels in the prenatal heart and is up-
regulated during the early postnatal period (Morkin, 2000).
Mechanical stress and hypothyroidism induce a shift from
a- toward b-MHC composition in the adult heart (Fatkin et al.,
2000; Gupta, 2007; Kiriazis and Kranias, 2000; Krenz and Rob-
bins, 2004; Vanderheyden et al., 2008), which correlates with
a decline in mechanical performance and contractile efficiency
(Lowes et al., 1997; Miyata et al., 2000; Stelzer et al., 2007).
Because relatively minor changes in the ratio of these two
myosin isoforms can have profound effects on cardiac contrac-
tility in human and rodent hearts (Herron and McDonald, 2002;
Korte et al., 2005; Rundell et al., 2005; Schiaffino and Reggiani,
1996), and because increased expression of b-MHC in the
myocardium decreases power output and contributes to
depressed systolic function in end-stage heart failure, the mech-
anisms that regulateMHC gene switching have been the focus of
intense interest.
Skeletal myofibers are also characterized by the expression of
particular myosin isoforms and other contractile proteins that
determine the efficiency of contraction (Bassel-Duby and Olson,
2006). In slow-twitch, type I fibers, which display oxidative
metabolism and high endurance, b-MHC is the predominant
myosin, whereas fast-twitch, type II myofibers express fast
myosins and are primarily glycolytic and susceptible to fatigue.
Thyroid hormone (T3) signaling represses b-MHC expression
and type I myofiber formation, and promotes the fast myofiber
phenotype. However, despite intense study, the exact regulatory
mechanism behind myofiber switching in response to T3
signaling and other cues has remained elusive.
Recently, we reported that an intron of the a-MHC gene
encodes a microRNA (miRNA), miR-208, that is required for up-
regulation of slow b-MHC in the adult heart in response to
stress and hypothyroidism (van Rooij et al., 2007). Given that
miR-208 and its host myosin, a-MHC, are only expressed in
the heart, these findings raised interesting questions as to
whether other miRNAs might control myosin switching and
contractile protein gene programs in fast versus slow skeletal
muscle.
miRNAs inhibit mRNA translation or promote mRNA degrada-
tion by annealing to complementary sequences in the 30 untrans-
lated regions (UTRs) of target mRNAs (Bartel, 2004). Individual
miRNAs have numerous targets, and individual mRNAs arelsevier Inc.
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Figure 1. Distinct Expression Patterns of MyomiRs
(A) Schematic representation of the genomic location of the miRNAs present in the different myosin genes. miR-208a and miR-208b share a comparable seed
region (nt 2–8) but differ at three bases in their 30 end (indicated in black). The seed region of miR-499 overlaps at 6 nt with miR-208a but differs significantly in the
30 region.
(B) Northern analysis on adult cardiac tissue shows that miR-208a expression correlates with the cardiac-specific expression of a-MHC, while miR-208b parallels
the predominant slow skeletal expression of b-MHC. miR-499 is coexpressed with Myh7b, a slowmyosin that is mainly expressed in the heart and soleus, a slow
skeletal muscle, but not in fast myofibers. Label indicates the mature miRNA.
(C) In situ hybridization shows that Myh7b is expressed specifically in the heart at E10.5 and in somites as early as E12.5 during mouse embryogenesis. Silver
grains are pseudocolored red. ht, heart; t, tongue.commonly targeted by multiple miRNAs, providing combinato-
rial complexity and broad regulatory potential to miRNA:mRNA
interactions. miRNAs often target multiple mRNAs with shared
functions and in so doing can exert robust control over complex
cellular processes through modulation of multiple interrelated
targets (Mourelatos et al., 2002; Stefani and Slack, 2008). The
T3 receptor associated protein-1 (Thrap1), which functions as
a positive and negative regulator of T3 signaling, is one target
of miR-208 that appears to mediate the functions of this miRNA
in the heart (van Rooij et al., 2007; Callis et al., 2009).
In the present study, we show that miR-208 is essential for the
expression not only of b-MHC in the heart, but also of a closely
relatedmyosin isoform,Myh7b (McGuigan et al., 2004). Remark-
ably, both of these genes encode slow myosins and contain
intronic miRNAs (miR-208b and miR-499, respectively) (Berezi-
kov et al., 2006; Landgraf et al., 2007) that are expressed in
both cardiac and slow skeletal muscle. Through gain- and
loss-of-function experiments in mice, we show that these
myosin-encoded miRNAs act within a network to control myosin
expression and skeletal myofiber phenotypes through the
repression of a collection of transcriptional repressors of slow
myofiber genes. Thus, myosin genes not only encode the major
contractile proteins of muscle, but act more broadly to control
muscle gene expression and performance through a network
of intronic miRNAs.
RESULTS
A Family of miRNAs Encoded by Myosin Genes
miR-208 is encoded by intron 27 of the mouse a-MHC gene,
which is expressed specifically in the heart (Figures 1A andDevelopm1B). Because of the important role of miR-208 in regulating
cardiac gene expression in response to stress (van Rooij et al.,
2007; Callis et al., 2009), we scanned other myosin genes for
possible intronic miRNAs. Indeed, intron 31 of the mouse
b-MHC gene is predicted to encode a closely related miRNA,
miR-208b, which has an identical seed sequence to miR-208
and differs at only three nucleotides in the 30 region (Figure 1A).
miR-208b is coexpressed with b-MHC, showing highest expres-
sion in soleus muscle, which is composed predominantly of slow
type I myofibers, and lower expression in adult heart (Figure 1B).
A third member of this miRNA family, miR-499, is encoded by
intron 19 of the mouse Myh7b gene (McGuigan et al., 2004),
a little-studied myosin gene that shares extensive homology
with b-MHC (Figure 1A). Myh7b and miR-499 are highly
expressed in the heart and are enriched in the soleus, compared
with gastrocnemius/plantaris (G/P), tibialis anterior (TA), or
extensor digitorum longus (EDL)muscles,whichcontain predom-
inantly fast myofibers (Figure 1B). Similar to b-MHC, Myh7b is
expressed in the embryonic heart and skeletal muscle, as re-
vealed by in situ hybridization (Figure 1C). We refer to this family
of miRNAs as MyomiRs, because of their location within and co-
expression with their corresponding myosin genes. Henceforth,
we refer tomiR-208 asmiR-208a to distinguish it frommiR-208b.
T3 Regulation ofMyh7b/miR-499 and b-MHC/miR-208b
Though Myh7b/miR-499 and b-MHC/miR-208b expression
marks slow, type I myofibers in skeletal muscle, these genes
display distinct regulation in the adult mouse heart, with
b-MHC/miR-208b being expressed at a low level and induced
to a high level in response to stress, and Myh7b/miR-499 being
constitutively expressed at a relatively high level. In the adultental Cell 17, 662–673, November 17, 2009 ª2009 Elsevier Inc. 663
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Figure 2. miR-208a Regulates Myh7b/miR-499
(A) Northern blot analysis of heart and skeletal muscle tissue ofmiR-208a/ animals shows that miR-499 expression is specifically extinguished in the heart while
the expression in soleus remains unaffected. Compare with lower panel of Figure 1B.
(B) Northern blot analysis of heart tissue shows that miR-208a regulates the expression of Myh7b/miR-499 in a stoichiometric manner. InmiR-208a+/ animals,
miR-499 and Myh7b expression is reduced by 50%, while miR-499 and Myh7b expression are eliminated in miR-208a/ animals. Myh7b and GAPDH were
detected by RT-PCR. GAPDH serves as a loading control.
(C) Northern blot analysis on cardiac samples of wild-type and miR-208a/ (KO) neonate and adult mice. miR-208b and miR-499 are expressed normally in
neonatal heart of miR-208a/ mice, whereas neither miRNA is expressed in adult miR-208a/ heart.
(D)Mice of the indicatedmiR-208a genotypewere treatedwith PTU, as indicated, andmiRNA expressionwas detected by northern blot. PTU treatment increases
miR-208b in wild-type animals, and this effect is significantly blunted in miR-208a/ animals.
(E) Expression of miR-499 in hearts from wild-type and MCK-miR-499 transgenic mice detected by northern blot.
(F) ReintroducingmiR-499 in the heart with anMCK-miR-499 transgene in themiR-208a/ background restores expression ofmiR-208b and b-MHC in response
to PTU treatment. Upper panels show northern blots of hearts from duplicate animals under each condition. Lower panels show b-MHC expression as detected
by real-time RT-PCR.
(G) Fast skeletal muscle troponins (TnnT3 and TnnI2) are upregulated in hearts of miR-208a/ animals. Introduction of the MCK-miR-499 transgene into
miR-208a/mice represses troponin expression as in wild-type. Results represent the average values obtained from two animals as detected by real-time PCR.heart, T3 signaling induces a-MHC transcription and represses
b-MHC expression (Morkin, 2000; Schuyler and Yarbrough,
1990). Inhibition of T3 biosynthesis with propylthiouracil (PTU)
derepresses the expression of b-MHC. To determine whether
miR-208b andmiR-499 are coregulated with their corresponding
myosin genes, we performed side-by-side comparison of myo-
sin and miRNA expression in response to PTU (see Figure S1
available online). Like b-MHC, miR-208b was upregulated in
the hypothyroid state induced by PTU, which could be reversed
by T3 supplementation. Myh7b and miR-499 were also upregu-
lated by PTU, but the magnitude of upregulation was blunted
compared with b-MHC/miR-208b because the basal level of
Myh7b/miR-499 expression was higher in the heart (Figure S1).
Overall, the expression of theMyomiRs paralleled the expression
of their host myosin genes during development and in response
to T3 signaling, consistent with the conclusion that the MyomiRs
are processed out of intronic sequences of their host myosin
mRNAs.664 Developmental Cell 17, 662–673, November 17, 2009 ª2009 ElsmiR-208a Is Required for Expression of Myh7b/miR-499
In light of the profound influence of miR-208a on cardiac gene
expression (van Rooij et al., 2007), we investigated whether
this miRNA might regulate the expression of subordinate
miRNAs in the heart by comparing the miRNA expression
profiles in hearts fromwild-type andmiR-208a/mice bymicro-
array analysis (Figure S2). The absence of miR-208a expression
inmiR-208a/ hearts served as an internal control for themicro-
arrays. Remarkably, we found that miR-499 expression was
extinguished in hearts of miR-208a/ mice, whereas it was
unaffected in the soleus, consistent with the cardiac-specific
expression of miR-208a (Figure 2A). The expression of miR-
499 is exquisitely sensitive to the level of miR-208a expression,
such that the expression of both miRNAs was reduced by
50% in hearts frommiR-208a+/mice (Figure 2B). The expres-
sion of miR-499 paralleled that of Myh7b, indicating a regulatory
role for miR-208a in the control of Myh7b transcription
(Figure 2B).evier Inc.
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Figure 3. Generation of miR-499 Null Mice
(A) Strategy to generate miR-499 mutant mice by homologous recombination.
The pre-miRNA sequence was replaced with a neomycin resistance cassette
flanked by loxP sites. The neomycin cassette was removed in the mouse
germline by breeding heterozygous mice to transgenic mice harboring the
CAG-Cre transgene.
(B) Detection of the miR-499mutation by PCR. Primers flanking the loxP site in
intron 19 of theMyh7b gene generate PCR products as indicated. The mutant
band in the PCR reaction is larger than the wild-type band due to replacement
of the miRNA with a larger loxP site.
(C) Detection of miR-499 and miR-208a transcripts by northern analysis of
hearts from wild-type, heterozygous, and miR-499 mutant mice.
(D) Detection of Myh7b expression by RT-PCR of RNA from heart and soleus
of mice of the indicated genotypes using primers flanking intron 19. Deletion of
miR-499 does not disrupt cardiac expression of Myh7b, while there is a
decrease in expression in soleus.
(E) Western analysis of a-MHC and b-MHC protein levels in hearts of neonatal
mice of the indicated genotypes in the absence (left) and presence (right) of
PTU. Two mice of each genotype were analyzed. Unlike miR-208a, miR-499
is not required for upregulation of b-MHC in response to PTU.DevelopmeAlthough miR-208a is required for upregulation of b-MHC in
the adult heart in response to stress and hypothyroidism (van
Rooij et al., 2007; Callis et al., 2009), expression of b-MHC and
miR-208b during the neonatal period is independent of miR-
208a (Figure 2C). Similarly, like the expression of its host gene,
b-MHC, miR-208b expression is absent in the adult heart
(Figure 2C). Based on the finding that miR-499 and Myh7b are
expressed at comparable levels in wild-type and miR-208a/
hearts of neonates while miR-208b is still present, and that
Myh7b/miR-499 expression is absent in adult miR-208a/
heart, we conclude that both miR-208a and miR-208b are
capable of activating Myh7b/miR-499 expression (Figure 2C).
While PTU upregulates miR-208b in wild-type hearts, this effect
is nearly absent inmiR-208a/ hearts (Figure 2D), and the slight
induction of miR-208b seen inmiR-208a/ animals treated with
PTU is apparently insufficient to activate miR-499 expression.
Thus, the expression of miR-208b and miR-499 correlates with
the expression patterns of their host myosin genes even in the
absence of miR-208a. The hearts of adult miR-208a/ mice
are essentially analogous to those of MyomiR nulls, since neither
miR-208b nor miR-499 are expressed at significant levels.
miR-499 Can Replace the Cardiac Functions
of miR-208a
miR-208a is required for both the upregulation of b-MHC in the
adult heart and the expression of Myh7b/miR-499. We investi-
gated whether miR-499 could replace the functions of miR-
208a by generating transgenic mice that expressed miR-499
under control of MCK regulatory elements, which direct expres-
sion in the heart and in skeletal muscle. Multiple transgenic lines
were obtained that expressed miR-499 in the heart at levels
approximately 3-fold above the endogenous level (Figure 2E).
As shown in Figure 2F, transgenic expression of miR-499 in
the heart of miR-208a/ mice was sufficient to restore the
expression of b-MHC andmiR-208b to normal levels in the pres-
ence of PTU. Genetic deletion of miR-208a also results in the
expression of fast skeletal muscle genes, such as the fast tropo-
nins TnnT3 and TnnI2, in the heart (van Rooij et al., 2007), and
transgenic expression of miR-499 in the absence of miR-208a
repressed cardiac expression of fast skeletal muscle genes
(Figure 2G). The finding that miR-499 alone is sufficient to
replace the functions of miR-208a in the heart suggests that
miR-499 is a downstream mediator of miR-208a actions.
Generation of miR-499 and miR-208b Null Mice
To further explore the functions of miR-499 and miR-208b
in vivo, we generated mutant mice with germline deletions of
the pre-miR regions of the Myh7b and b-MHC introns, respec-
tively, encoding these miRNAs. LoxP sites were introduced
into the corresponding introns at both ends of themiRNA-coding
regions (Figures 3A and 4A). Breeding of these mice to mice
expressing a CAG-Cre transgene, which is expressed ubiqui-
tously, allowed deletion of the corresponding miRNA and its
complete absence in homozygous mutant animals as shown
by PCR using primers flanking the loxP site (Figures 3B and 4B).
miR-499/ andmiR-208b/ mice were obtained at Mendelian
ratios from heterozygous intercrosses and displayed no overt
abnormalities (Tables S1 and S2; data not shown).ntal Cell 17, 662–673, November 17, 2009 ª2009 Elsevier Inc. 665
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miRNAs in Myosin Genes Regulate Muscle PerformanceNorthern blot analysis on adult heart tissue showed that miR-
208a expression was unperturbed by the deletion of miR-499
(Figure 3C). We confirmed that Myh7b mRNA expression was
unaltered in hearts of miR-499/ mice, while there was a
decrease in the soleus as detected by RT-PCR using primers
in exons flanking the deletion in intron 19 (Figure 3D). Western
blot analysis for both a-MHC and b-MHC showed no difference
between wild-type ormiR-499/mice, and a comparable upre-
gulation in b-MHC expression in wild-type andmiR-499/mice
in response to PTU (Figure 3E). These data, combined with the
finding that overexpression of miR-499 in miR-208a/ mice
can restore b-MHC expression and repress fast skeletal muscle
genes in the heart, indicate that both miR-208a and miR-499
must be absent for the blockade of b-MHC expression in
response to stress and hypothyroidism.
Deletion of miR-208b also did not alter b-MHC expression as
determined by both RT-PCR using primers in exons flanking the
deletion in intron 31 (Figure 4C) and western blot analysis on
neonatal cardiac tissue of miR-208b/ mice (Figure 4D). Thus,
miR-208a appears to function as the most ‘‘upstream’’ and
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Figure 4. Generation of miR-208b Null Mice
(A) Strategy to generate miR-208b mutant mice by homologous recombina-
tion. The pre-miRNA sequence was replaced with a neomycin resistance
cassette flanked by loxP sites. The neomycin cassette was removed in the
mouse germline by breeding heterozygous mice to transgenic mice harboring
the CAG-Cre transgene.
(B) Detection of the miR-208b mutation by PCR. Primers flanking the loxP site
in intron 31 of the b-MHC gene generate PCR products as indicated.
(C) Detection of b-MHC expression by RT-PCR of RNA from hearts of mice of
the indicated genotypes using primers flanking intron 31. Deletion of miR-208b
does not disrupt expression of b-MHC.
(D) Detection of b-MHC by western blot analysis of heart from P0 mice of the
indicated genotypes, showing that b-MHC expression is not altered by dele-
tion of miR-208b. GAPDH was detected as a loading control.666 Developmental Cell 17, 662–673, November 17, 2009 ª2009 Elsdominant regulatory miRNA to control expression of both slow
myosins, b-MHC and Myh7b, and their corresponding intronic
miRNAs in the heart, whereas miR-499 and miR-208b are not
individually required for expression of either myosin or other
members of the MyomiR trio.
Control of Skeletal Muscle Fiber Type by miR-499
and miR-208b
The cardiac specificity of miR-208a led us to investigate the
potential involvement of miR-208b and miR-499 in the control
of skeletal muscle fiber types. Deletion of either miR-208b or
miR-499 did not alter the expression of the other miRNA in the
soleus (data not shown), and fiber type analysis showed little
or no difference in the number of type I myofibers in either of
these mutant mice compared to wild-type (Figure S3).
Wondering whether the homology of miR-208b and miR-499
and their coexpression in soleus might allow redundant functions
that were masked in mice with either single gene deletion, we
generated miR-208b/; miR-499/ double knockout (dKO)
mice. These mice were obtained at predicted Mendelian ratios
from transheterozygous intercrosses and displayed no overt
abnormalities (TableS3).However,stainingofhistological sections
for myofiber type with metachromatic ATPase stain and immuno-
histochemistry against b-MHC showed a substantial loss of type I
myofibers in the soleus of dKOmice (Figures 5A and 5B). The loss
of slowmyofibers in dKOmicewas also evidenced by the reduced
expressionof slow b-MHCat theprotein andmRNA levels (Figures
5Cand5E), andbyaconcomitant increase in theexpressionof fast
type IIx/d and type IIb myosin isoforms (Figures 5C and S3).
Conversely, forced expression of miR-499 under control of
MCK regulatory elements was sufficient to induce a complete
conversion of all fast myofibers in soleus to a slow, type I pheno-
type (Figures 5A–5C). Analysis of gene expression in the soleus
by real-time PCR also demonstrated an induction of the slow
fiber gene program in response to miR-499 overexpression
(Figure 5F). In the TA and EDL, which contain predominantly
fast myofibers, we observed a pronounced induction of slow
myofiber gene expression in MCK-miR-499 transgenic mice
(Figure 5F). Metachromatic ATPase staining of TA and EDL
muscles from MCK-miR-499 transgenic animals also revealed
conversion to a slower myofiber type (Figure S3). Separation of
myosin isoforms by gel electrophoresis indicated a switch from
fast type IIb fibers to slower type IIx/d and type IIa fibers in the
EDL and TA of transgenic mice (Figure 5C). This shift in fiber
type was confirmed by real-time PCR for fiber-type-specific
myosins (Figure S3). In contrast, fast myofiber genes were
repressed in both soleus and EDL muscles from MCK-miR-499
transgenic mice (Figure 5E). Even more remarkably, when mice
were subjected to a regimen of forced treadmill running, the
miR-499 transgenic animals ran more than 50% longer than
wild-type littermates, indicative of enhanced endurance result-
ing from the reprogramming of fast myofibers to a slower fiber
type (Figure 5F). We conclude that miR-208b and miR-499
redundantly program skeletal myofibers to a slow phenotype
at the expense of fast myofibers.
MyomiR Targets and Mechanism
To begin to define the mRNA targets of MyomiRs that mediate
their influence on myosin expression and myofiber phenotypes,evier Inc.
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miRNAs in Myosin Genes Regulate Muscle Performancewe used targeting algorithms (TargetScan) to search for pre-
dicted targets that were evolutionarily conserved and encoded
transcriptional regulators implicated in myofiber gene expres-
sion. In addition to the thyroid hormone receptor coregulator
Thrap1, shown previously to be a target for repression by miR-
208a in the heart (van Rooij et al., 2007; Callis et al., 2009), we
identified several transcriptional repressors among the predicted
targets of the MyomiRs (Figure S4). These include Sox6, Purb,
and Sp3, each of which has been reported to repress b-MHC
expression (Adolph et al., 1993; Azakie et al., 2006; Gupta
et al., 2003; Hagiwara et al., 2005, 2007; Ji et al., 2007; Tsika
et al., 2004; von Hofsten et al., 2008); and HP-1b, a corepressor
of MEF2 (Zhang et al., 2002), which activates slow fiber gene
expression (Wu et al., 2000).
Remarkably, the 30 UTR of Sox6 mRNA contains four evolu-
tionarily conserved target sites for miR-499, one of which is
also a predicted site for miR-208 (Figure S4). The 30 UTRs of
Purb and HP-1b each contain single conserved predicted target
sequences for miR-499 and miR-208, while Sp3 contains a
conserved miR-208 targeting sequence. We cloned the
30 UTRs of each of these predicted targets downstreamof a lucif-
erase reporter and assayed for repression by miR-208 and miR-
499 in transfected COS cells. Expression of the MyomiRs
repressed wild-type 30 UTR-luciferase reporter constructs, but
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Figure 5. Control of Skeletal Muscle Fiber Type by miR-208b and miR-499
(A) Detection of type I myofibers in soleus of wild-type,miR-208b/; miR-499/ dKO, and MCK-miR-499 transgenic mice by metachromatic ATPase staining.
Scale bar, 500 mm.
(B) Immunohistochemistry for b-MHC to identify type I myofibers in the soleus of wild-type,miR-208b/; miR-499/ dKO, and MCK-miR-499 transgenic mice.
Scale bar, 500 mm.
(C) Identification of myosin isoform content of soleus, EDL, and TA muscles from wild-type,miR-208b/; miR-499/ dKO, and MCK-miR-499 transgenic mice
by gel electrophoresis.
(D) The percentage of type I myofibers within soleus muscles of wild-type, MyomiR mutant, and MCK-miR-499 transgenic mice was determined as shown in (B).
(E) b-MHC mRNA levels in skeletal muscle of miR-208b/; miR-499/ dKO adult mice were detected by real-time PCR. Loss of MyomiRs in skeletal muscle
results in repression of b-MHC.
(F) Expression of slow and fast myofiber genes in soleus, TA, and EDL muscles of MCK-miR-499 transgenic mice compared to their level of expression in
wild-type muscles (set at a value of 1), as detected by real-time PCR. Transgenic overexpression of miR-499 is sufficient to upregulate slow myofiber genes
and repress fast myofiber genes in soleus and EDL.
(G) Wild-type (n = 4) and MCK-miR-499 transgenic (n = 5) mice were subjected to a regimen of forced running to exhaustion on a treadmill. The time to run to
exhaustion of each mouse is shown. p = 0.0039.Developmental Cell 17, 662–673, November 17, 2009 ª2009 Elsevier Inc. 667
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the conserved targeting sequence (Figure 6A). Similarly, wild-
type luciferase reporter constructs were repressed in C2C12
cells as MyomiR expression increased over the course of differ-
entiation, while mutated constructs displayed no change in
activity (Figures 6B and 6C). Consistent with previous results,
the 30 UTR of Thrap1 displayed repression by both miR-208a
and miR-499 (data not shown).
To further validate the above repressors as potential targets of
MyomiRs, we compared the expression of the corresponding
proteins in cardiac extracts from wild-type and miR-208a/
mice (Figure 7A). Consistent with a repressive effect of miR-
208a on their expression, Purb, Sp3, and HP-1b proteins were
elevated in expression in hearts from mutant mice, while their
mRNA levels were unchanged (data not shown). Additionally,
Sox6 mRNA was upregulated in miR-208a/ hearts, indicative
of a destabilizing effect of miR-208a on Sox6 mRNA. Transgenic
expression of miR-499 was sufficient to reduce Sox6 mRNA
expression inmiR-208a/ hearts to wild-type levels (Figure 7B).
In addition, Sox6 mRNA levels were reduced in skeletal muscles
of MCK-miR-499 transgenic mice (Figure 7D). Such downregula-
tion of Sox6 suggests that Sox6 mediates, at least in part, the
increase in slow and decrease in fast myofiber gene expression
in MCK-miR-499 transgenic mice, as shown in Figure 5F.
Transgenic Expression of Sox6 and Purb Phenocopies
MyomiR Gene Deletions
To further validate Sox6 and Purb as potential mediators of
MyomiR function, we generated MCK-Sox6 and MCK-Purb
transgenic mice. MCK-Sox6 mice appeared normal at birth;
however, they demonstrated retarded growth at postnatal day
8 and ultimately died by 28 days of age. Analysis of multiple F0
transgenic animals revealed that simply elevating the expression
of Sox6 by 3-fold in the neonatal heart was sufficient to extin-
guish expression of Myh7b and miR-499 (Figure 7C), and that
overexpression in skeletal muscle strongly repressed b-MHC
and slow TnnI1 transcript levels (Figure 7E). Immunohistochem-
istry for b-MHC on skeletal muscle sections revealed a complete
loss of type I fibers in MCK-Sox6 mice (Figure 7F). MCK-Purb
transgenic mice demonstrated that a 1.4-fold increase in Purb
expression was sufficient to repress b-MHC expression in skel-
etal muscle at the mRNA level, but had little effect on the overall
number of type I fibers (Figure 7G and data not shown). Thus,
overexpression of Sox6 at similar levels to those in the miR-
208a/ heart, in addition to relatively modest elevation in
expression of Sox6 and Purb to levels comparable to those in
MyomiR dKO mice (Figures 7E and 7G), was sufficient to evoke
myofiber phenotypes similar to those of miR-208a/ and
MyomiR dKO mice. These results provide strong support for
the conclusion that these transcriptional repressors mediate
the actions of MyomiRs on slow myofiber gene expression.
In contrast, these targets did not activate the expression of fast
TnnI2 or TnnT3 (Figures 7E and 7G), as seen in miR-208b/;
miR-499/ dKO mice. The latter findings suggest that Sox6
and Purb mediate the actions of miR-499 and miR-208 on the
slow myofiber gene program, and that other targets of these
MyomiRs are required for the activation of fast myofiber genes.
DISCUSSION
The results of this study reveal a network of miRNAs within
myosin genes that regulates myosin expression, fiber type
gene expression, and muscle performance. The functions of
myosin genes thus extend far beyond the mere expression of
myosin proteins to the control of myriad functions of striated
muscles. A model to account for our results is shown in Figure 8.
Functions of MyomiRs in the Heart
As schematized in Figure 8, a-MHC andmiR-208a sit atop a hier-
archy of regulatory steps leading to myofiber diversification,
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Figure 6. MyomiRs Directly Repress Predicted Target Genes
(A) Luciferase studies of predicted MyomiR target transcripts. Wild-type and mutant Sox6, Purb, Sp3, and HP-1b 30 UTRs were cloned into a luciferase reporter
plasmid. These constructs were cotransfected into COS cells with expression vectors for miR-208a or miR-499. Luminescence values were assayed 48 hr post
transfection and were normalized to b-galactosidase activity.
(B) Expression of MyomiRs increases following C2C12 myoblast differentiation. Relative levels of miR-208b and miR-499 expression were detected by real-time
PCR at days 0 and 5 of C2C12 differentiation.
(C) Wild-type, but not mutant luciferase, reporter constructs are repressed by MyomiRs in C2C12 cells.668 Developmental Cell 17, 662–673, November 17, 2009 ª2009 Elsevier Inc.
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miRNAs in Myosin Genes Regulate Muscle Performancestress-responsiveness, and thyroid hormone sensitivity of the
heart. In the mouse heart, miR-208a, encoded by a-MHC, is
required for upregulation of b-MHC and miR-208b in response
to stress and hypothyroidism. miR-208a also regulates the ex-
pression of Myh7b and its intronic miRNA, miR-499; however,
this regulatory step is distinct from the regulation of b-MHC/
miR-208b in that Myh7b/miR-499 are highly expressed in the
adult heart in the absence of stress, whereas b-MHC/miR-
208b require stress or hypothyroidism for expression. In addition
to the requisite role of miR-208a in the expression of b-MHC and
Myh7b in the adult heart, miR-208a is also required for repres-
sion of fast muscle genes in the heart.
Within the adult mouse heart, a-MHC is the predominant
myosin, accounting for more than 90% of myosin expression
(Lompre et al., 1984), and miR-208a is the dominant miRNA
among the trio of MyomiRs. Although miRNAs are typically envi-
sioned to function as fine-tuners of gene expression, miR-208a
operates in a precise, stoichiometric manner to control the ex-
pression of Myh7b/miR-499 such that Myh7b/miR-499 expres-
sion is reduced by 50% in hearts of miR-208a+/ mice and is
extinguished in hearts of miR-208a/ mice. Forced expression
of miR-499 inmiR-208a/ hearts restores expression of b-MHC
and represses ectopic expression of fast muscle genes, consis-
tent with the conclusion that miR-499 functions downstream of
miR-208a. Notably, transgenic expression of miR-499 in the
hearts of miR-208a/ mice also reactivates the expression of
Myh7b, indicative of a positive autoregulatory loop (Figure 8).
In large animals, b-MHC is the predominant myosin in the
adult heart, so we presume that miR-208b, which shares an
identical seed sequence with miR-208a, fulfills the functions of
miR-208a in large animals. Whether miR-208b is required for
pathological remodeling of hearts with predominantly b-MHC
expression (Lompre et al., 1991), as is miR-208a in mice (van
Rooij et al., 2007), is an important issue with respect to the
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Figure 7. Target Proteins that Mediate the Actions of MyomiRs
(A) Western blot analysis of miR-208/499 target expression in adult wild-type (WT) andmiR-208a/ (KO) mouse heart lysate. Relative expression was calculated
from comparison of band intensity following normalization to GAPDH loading control.
(B) Sox6 mRNA levels are elevated in the miR-208a/ heart as measured by real-time PCR. Transgenic expression of miR-499 abolished the increase in Sox6
mRNA in hearts lacking miR-208a.
(C) Myh7b and miR-499 are repressed in the hearts of MCK-Sox6 transgenic mice. Transcript levels were measured in the hearts of P8 transgenic mice and
wild-type controls (WT) by real-time PCR.
(D) Real-time PCR indicates that Sox6 mRNA levels are depressed in skeletal muscle of MCK-miR-499 mice.
(E) Sox6 mRNA transcript is overexpressed in MyomiR dKO skeletal muscle. MCK-Sox6 transgenic mice exhibit repression of slow skeletal muscle genes and
unaltered levels of fast skeletal troponins in skeletal muscle. Expression was measured by real-time PCR in total hind limb muscle of MCK-Sox6 transgenic mice
and wild-type (WT) controls.
(F) Immunohistochemistry for type I myosin (b-MHC) in the hind limb of MCK-Sox6 transgenic mice indicates an absence of type I fibers in the EDL of transgenic
mice as compared with wild-type (WT) littermate controls. Scale bar, 100 mm.
(G) PurbmRNA transcript is overexpressed in MyomiR dKO skeletal muscle. MCK-Purb transgenic mice demonstrate repression of slow skeletal muscle genes
and unaltered fast skeletal gene expression. Expression was measured by real-time PCR in total hind limb muscle of MCK-Purb transgenic mice and wild-type
(WT) controls.Developmental Cell 17, 662–673, November 17, 2009 ª2009 Elsevier Inc. 669
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human heart disease.
There are several other noteworthy conclusions to be drawn
about the regulation and functions of MyomiRs in the heart
based on our findings with MyomiR mutant mice. First, the
cardiac regulatory circuitry among the MyomiRs and their host
myosins appears to be operative specifically in the adult, but
not in the fetal, heart. We base this conclusion on the finding
that b-MHC and Myh7b are expressed normally in neonatal
hearts of miR-208a/ mice, whereas these myosin genes are
silenced in heart of adult mutant mice. Thus, there must be a
regulatory switch that distinguishes neonatal and adult cardiac
gene programs with respect to their sensitivity to MyomiR func-
tions. Second, none of the MyomiRs are essential for function of
the adult heart, as evidenced by the phenotype of miR-208a/
mice, which are essentially MyomiR nulls, since the absence of
miR-208a abolishes the expression of miR-208b and miR-499.
Thus, the MyomiRs appear to function primarily to adapt adult
cardiac gene expression to physiological and pathological
signaling rather than to control cardiac homeostasis.
Functions of MyomiRs in Skeletal Muscle
Unlike a-MHC and miR-208a, which are expressed only in
the heart, b-MHC/miR-208b and Myh7b/miR-499 are also
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Figure 8. Control of Myosin and Fast Versus Slow Muscle Gene
Expression by the MyomiR Network
In the adult heart, miR-208a encoded by the a-MHC gene is required for
expression of b-MHC and Myh7b, which encode miR-208b and miR-499,
respectively. Activation ofMyh7b bymiR-208a is constitutive, whereas activa-
tion of b-MHC also requires stress signals or absence of thyroid hormone.
In slow skeletal muscle, Myh7b and b-MHC are regulated independently of
miR-208a. miR-208a, miR-208b, and miR-499 repress the expression of a
common set of transcriptional repressors that repress slow myosin and the
slow myofiber gene program at the expense of fast muscle gene expression.
Activation of the slowmyofiber gene program also creates a positive feedback
loop via the expression of miR-208b andmiR-499, which further reinforce slow
muscle gene program. Regulatory interactions within the blue box are shared
by cardiac and slow skeletal muscle.670 Developmental Cell 17, 662–673, November 17, 2009 ª2009 Elexpressed in slow skeletal muscle. The latter two myosins and
their intronic miRNAs appear to function in a shared regulatory
circuit in cardiac and skeletal muscle; however, the upstream
inputs into this myosin/miRNA circuit differ in cardiac and skel-
etal muscle in multiple ways (Figure 8). For example, the expres-
sion of miR-208b and miR-499 in slow skeletal muscle does not
require an upstream MyomiR, since both of these miRNAs are
expressed normally in the absence of the other, as shown from
our analysis of miR-208b and miR-499 null mice. The activation
of slow myofiber genes in skeletal muscle depends on calcium
signaling through calcineurin and various kinases (Bassel-Duby
and Olson, 2006; Wu et al., 2000), leading us to propose that
b-MHC and Myh7b are activated independently through such
signals, resulting in the production of their encoded MyomiRs,
which then reinforce the slow skeletal muscle gene program
through the actions of their targets. Importantly, this model infers
the existence of a positive feedback loop whereby the targets of
miR-208b and miR-499 in slow skeletal muscle enhance their
own expression via their targets, which act on their hostmyosins.
Such a mechanism also enables MyomiRs to function as binary
regulators of slow versus fast muscle gene programs—acti-
vating slow and repressing fast—through their downstream
targets. Moreover, we have observed that an increase of Myo-
miR levels in the soleus, TA, and EDL elicits a distinct shift toward
the slow phenotype in each muscle. In addition to upregulating
b-MHC, transgenic expression of miR-499 primarily drives these
muscles to shift one myosin isoform slower in the sequential
transition toward a slow myofiber phenotype (Pette and Staron,
1997). We hypothesize that divergent gene expression profiles,
as well as different frequencies of muscle use between the
soleus, TA, and EDL,may be responsible for the distinct changes
we observe in response to gain of MyomiR function.
A Collection of Transcriptional Repressors Downstream
of MyomiRs
It has been demonstrated that miRNAs function by finely modu-
lating the expression of their downstream target genes at the
protein level (Baek et al., 2008). Consistent with this idea, our
results demonstrate that the MyomiRs target a cohort of tran-
scriptional repressors tomediate their actions on striatedmuscle
gene expression and function. Among their targets, Sox6, Purb,
and Sp3 have previously been shown to repress the expression
of slow skeletal muscle genes, but the mechanisms that control
the expression of these repressors have not been investigated.
In Sox6 mutant mice, slow-fiber-type-specific gene expression,
including the expression of b-MHC, is increased, whereas fast
myofiber genes are repressed (Hagiwara et al., 2005, 2007;
von Hofsten et al., 2008). It has been proposed that the repres-
sive influence of Sox6 on b-MHC expression ismediated through
direct binding of Sox6 to the promoter of the gene (Hagiwara
et al., 2007). Purb, a single-stranded DNA binding protein, coop-
erates with Sp3 to repress b-MHC expression (Ji et al., 2007).
Thus, by dampening the expression of Sox6, Purb, and Sp3,
the MyomiRs enable the expression of b-MHC and other genes
under the inhibitory influence of the repressors. Conversely, in
the absence of MyomiRs, the expression of these repressors is
enhanced, resulting in the inhibition of b-MHC and other down-
stream targets. Our finding that transgenic overexpression of
Sox6 or Purb represses slow genes, but does not activate fastsevier Inc.
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mediates fast muscle gene expression downstream of MyomiRs
or could require the combined actions of multiple targets.
In addition to the above targets, HP-1b, a transcriptional
repressor shown previously to function as a class II HDAC core-
pressor, is also a target for repression by the MyomiRs. Class II
HDACs function as calcium-sensitive repressors of the MEF2
transcription factor, which is necessary and sufficient for activa-
tion of slow myofiber gene expression (Potthoff et al., 2007). The
repressive influence of MyomiRs on HP-1b expression would
therefore be expected to diminish the repressive influence of
class II HDACs on MEF2, promoting the expression of slow
muscle genes. Thrap1, another validated target of the MyomiRs,
functions as a modulator of thyroid hormone signaling and likely
plays a key role in regulating the response of b-MHC and myo-
fiber gene programs to hypothyroidism.
Interestingly, our data indicate that the MyomiR family func-
tions redundantly in vivo,while luciferase reporter assays suggest
that these micoRNAs may exhibit differential effects on target
gene repression. These differences in our reporter assays may
be attributed to dissimilarity in sequence outside of the seed
region of miR-208 and miR-499, which may have effects on the
miRNA:target interactions that dictate repression, or possibly to
differences in miRNA-associated machinery in vitro and in vivo.
Implications for Gene Regulatory Networks
Sequence analysis of MHC genes indicates that Myh7b is the
most ancient of this trio of myosins and that gene duplications
gave rise to a- and b-myosins. The MyomiRs are conserved
from fish to human genomes, but do not exist in invertebrates,
suggesting that the ancestralMyh7b gene contained the ances-
tral MyomiR in an intron, and when that myosin gene duplicated,
so too did its intronic MyomiR. It is intriguing, in this regard, that
the existence of MyomiRs correlates with myofiber diversifica-
tion and the acquisition of hormonal sensitivity and stress
responsiveness. These findings argue strongly for selection
pressure to maintain not only the conserved sequence of Myo-
miRs, and presumably of their targets, but also the integration
of this family of miRNAs into myosin genes, so as to ensure their
regulatory relationship. The incorporation of MyomiRs into the
introns of myosin genes that they regulate also provides an effi-
cient means of ensuring the coregulation of the miRNA and the
gene programs under its control, rather than creating separate
sets of cis-regulatory elements to control expression of the
miRNA and the myosin gene.
The functions and regulation of the MyomiR network serve as
a paradigm for phenotypic control. This elaborate regulatory
network provides communication between genes and reveals
an unanticipated breadth of functions of myosin genes, previ-
ously recognized simply for their roles as protein-coding genes.
We speculate that protein-coding genes with central roles in the
functionality of other tissues will also be found to encode families
of miRNAs that dictate the functions of those tissues, especially
in settings of disease. Perhaps most provocative is the realiza-
tion that miRNA functions can be perturbed without deleterious
consequences on tissue function, but with dramatic effects
on signal-dependent tissue remodeling responses. As such,
miRNAs represent potentially powerful disease modifiers and
therapeutic targets.DevelopmEXPERIMENTAL PROCEDURES
Northern Blot Analysis
Total RNA was isolated from mouse and human cardiac tissue samples by
using Trizol reagent (GIBCO/BRL). Northern blots to detect miRNAs were
performed as described previously (van Rooij et al., 2006). U6 was detected
as a loading control using the following primers in RT-PCR reactions: U6
forward: 5-GTGCTCGCTTCGGCAGC-3, U6 reverse: 5-AAAATATGGAACGC
TTCACGAATTTGCG-3.
RNA In Situ Hybridization
Tissues used for histology were incubated in Krebs-Henselheit solution, fixed
in 4% paraformaldehyde, sectioned, and processed for in situ hybridization by
standard techniques (Shelton et al., 2000). 35S-labeled RNA probes were
generated using Maxiscript kit (Amersham). Signals were pseudocolored in
red using Adobe Photoshop.
miRNA Microarray Analysis
Microarray assay was performed using a service provider (LC Sciences, Hous-
ton). The assay started from 10 mg total RNA from cardiac tissue of both
wild-type and miR-208/ mice, which was size fractionated, and the small
RNAs (<300 nt) isolated were 30-extended with a poly(A) tail using poly(A) poly-
merase. An oligonucleotide tag was then ligated to the poly(A) tail for later
fluorescent dye staining. Hybridization was performed overnight on a mParaflo
microfluidic chip on which each detection probe consisted of a chemically
modified nucleotide coding segment complementary to target miRNA (from
miRBase, http://microrna.sanger.ac.uk/sequences/). After RNA hybridization,
tag-conjugating Cy5 dyes were circulated through the microfluidic chip for
dye staining. Fluorescence images were collected using a laser scanner (Gen-
ePix 4000B, Molecular Device) and digitized using Array-Pro image analysis
software (Media Cybernetics). Data were analyzed by first subtracting the
background and then normalizing the signals using a Locally-weighted
Regression (LOWESS filter). The ratio of the two sets of detected signals
(log2 transformed, balanced) and p values of the t test were calculated; differ-
entially detected signals were those with p < 0.01.
RT-PCR and Real-Time Analysis
RT-PCR with random hexamer primers (Invitrogen) was performed on RNA
samples, after which the expression of a subset of genes was analyzed by
either PCR or quantitative real-time PCR using Taqman probes purchased
from ABI.
Generation of Transgenic Mice
A mouse genomic fragment flanking miR-499 was subcloned into a muscle-
specific expression plasmid containing the MCK enhancer and human GH
poly(A)+ signal (Sternberg et al., 1988). Genomic DNAwas isolated frommouse
tail biopsies and analyzed by PCR using primers specific for the human GH
poly(A)+ signal.
Western Blot Analysis
Myosin was extracted from cardiac tissue as described (Bar and Pette, 1988).
MHC isoforms were separated by SDS-PAGE and western blotting was per-
formed with mouse monoclonal a-MHC (BA-G5) (ATCC, Rockville, MD) and
mouse monoclonal anti-myosin (slow, skeletal M8421) (Sigma, MO), which is
highly specific for b-MHC. Total heart lysate was prepared by homogenizing
tissue in RIPA buffer, was resolved by SDS-PAGE, and was analyzed to detect
HP-1b, Purb, and Sp3 using mouse monoclonal anti-HP-1b (Cell Signaling
#2613) at a dilution of 1:1000, anti-Purb (a gift from Robert J. Kelm Jr. at
University of Vermont College of Medicine; Kelm et al., 1999) at a dilution
1:1000, and anti-Sp3 (Abcam ab18334) at a dilution of 1:200. Anti-mouse
IgG conjugated to horseradish peroxidase (Biorad) at a dilution of 1:5000
was used as a secondary antibody, followed by detection with ECL detection
kit (Amersham).
Generation of miR-499 and miR-208b Mutant Mice
To generate the miR-499 targeting vector, a 4.9 kb region (50 arm) extending
upstream of the miR-499 coding region was ligated into the pGKneoF2L2
Dta targeting plasmid upstream of the loxP sites and the Frt-flanked neomycinental Cell 17, 662–673, November 17, 2009 ª2009 Elsevier Inc. 671
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miRNAs in Myosin Genes Regulate Muscle Performancecassette. A 2.6 kb fragment (30 arm) was ligated into the vector between the
neomycin resistance and Dta negative selection cassettes. Targeted ES cells
carrying the disrupted allele were identified by Southern blot analysis with 50
and 30 probes. Three miR-499 targeted ES clones were identified and used
for blastocyst injection. A comparable approach was taken to generate the
miR-208b targeting vector, with a 4.9 kb region extending upstream of the
miR-208b coding region functioning as the 50 arm and a 3.5 kb fragment func-
tioning as the 30 arm. The resulting chimeric mice were bred to C57BL/6 to
obtain germline transmission of the mutant allele. PCR primer sequences
are available upon request.
Fiber-Type Staining
Soleus, GP, TA, and EDL muscles were isolated at 8 weeks of age and were
embedded in a 3:1 ratio of Tissue Freezing Medium to gum tragacanth.
Samples were flash frozen and sectioned on a cryostat-microtome. Metachro-
matic ATPase staining was performed as previously described (Ogilvie and
Feeback, 1990).
Forced Running
Forced treadmill running of 6-week-old wild-type and MCK-miR-499 trans-
genic mice was performed as follows. Animals were trained on the treadmill
(Colombus Instruments, 10% incline) for 5 min at 7 m/min for 2 consecutive
days. The following day mice were run at 8 m/min for 30 min, then 9 m/min
for 15 min, followed by 10 m/min for 15 min. Finally, speed was incrementally
increased by 1 m/min every 10 min until the mouse exhibited exhaustion. The
end point was reached when a mouse received repeated electrical stimuli for
greater than 5 s.
MHC Electrophoresis
Myosin was isolated from skeletal muscle and run on glycerol-SDS-PAGE gels
as previously described (Talmadge and Roy, 1993). Gels were stained with a
silver nitrate staining kit (Biorad).
Cell Culture, Transfection, and Luciferase Assays
A 300–500 bp genomic fragment encompassing the miR-208a or miR-499
coding region was amplified by PCR and ligated into pCMV6. Full-length
30 UTRs of Sox6, Sp3, HP-1b, and Purb were cloned into the pMiR-report
vector (Ambion). Cell culture, transfection, and luciferase studies were per-
formed as previously described (van Rooij et al., 2007). Mutations in the
30 UTRs alter the 2nd and 3rd nucleotides of the targeting sequence, and were
genereated using QuickChange Lightning kit (Stratagene).
Immunohistochemistry
Tissue samples were fixed in 4% paraformaldehyde and embedded in paraffin
for sectioning. Deparaffinized sections were permeabilized with 0.04% Pro-
nase E, then blocked in 0.5% bovine serum albumin/5% normal goat serum
in PBS. NOQ7.5.4D (1:16,000) was used for primary detection of type I myosin,
and HRP-conjugated secondary antibody (Sigma A8924) followed by DAB
chromagen reaction was used for detection. Samples were then counter-
stained with hematoxylin.
Analysis of Transgenic Animals
Two or three F1 transgenic lines of MCK-miR-499 andMCK-Purb animals, and
three F0 transgenic MCK-Sox6 animals, were analyzed in this study.
Statistical Analysis
All graphs represent mean values ± SD. *p < 0.05 as calculated by unpaired
t test.
Animal Care
All animal procedures were previously approved by the Institutional Animal
Care and Use Committee at University of Texas SouthwesternMedical Center.
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